678 related articles for article (PubMed ID: 35941696)
1. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
[TBL] [Abstract][Full Text] [Related]
2. Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes.
Li L; Hui H; Jia X; Zhang J; Liu Y; Xu Q; Zhu D
Sci Rep; 2016 Dec; 6():37894. PubMed ID: 27905403
[TBL] [Abstract][Full Text] [Related]
3. One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study.
Lu J; Shen SM; Ling Q; Wang B; Li LR; Zhang W; Qu DD; Bi Y; Zhu DL
Stem Cell Res Ther; 2021 Jun; 12(1):340. PubMed ID: 34112266
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc
Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S
Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of insulin in a type 1 diabetic rat model by injection of manipulated mesenchymal stem cells with an insulin construct driven by a glucose-sensitive promoter in the port vein.
Mohammad Dezashibi H; Farzad-Mohajeri S; Bandehpour M; Shabani A; Kazemi B
Cell Biochem Funct; 2023 Dec; 41(8):1412-1421. PubMed ID: 37877623
[TBL] [Abstract][Full Text] [Related]
6. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
Xiao N; Zhao X; Luo P; Guo J; Zhao Q; Lu G; Cheng L
Cytotherapy; 2013 Nov; 15(11):1374-84. PubMed ID: 24094489
[TBL] [Abstract][Full Text] [Related]
7. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
Front Immunol; 2019; 10():619. PubMed ID: 31001253
[TBL] [Abstract][Full Text] [Related]
9. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice.
Yin Y; Hao H; Cheng Y; Gao J; Liu J; Xie Z; Zhang Q; Zang L; Han W; Mu Y
Int Immunopharmacol; 2018 Jul; 60():235-245. PubMed ID: 29778021
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effects of Insulin-Producing Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Type 1 Diabetes Mouse Model.
Park YM; Yang CM; Cho HY
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805883
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
12. Gastrin producing syngeneic mesenchymal stem cells protect non-obese diabetic mice from type 1 diabetes.
Gaudreau MC; Gudi RR; Li G; Johnson BM; Vasu C
Autoimmunity; 2022 Mar; 55(2):95-108. PubMed ID: 34882054
[TBL] [Abstract][Full Text] [Related]
13. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
Sharma A; Rani R
Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
[TBL] [Abstract][Full Text] [Related]
14. The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.
Ma Y; Wang L; Yang S; Liu D; Zeng Y; Lin L; Qiu L; Lu J; Chang J; Li Z
Stem Cell Res Ther; 2021 Jul; 12(1):385. PubMed ID: 34233739
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord-derived mesenchymal stem cells alleviate insulin resistance in diet-induced obese mice via an interaction with splenocytes.
Xue J; Gao J; Gu Y; Wang A; Yu S; Li B; Yin Y; Wang J; Su W; Zhang H; Ren W; Gu W; Lv Z; Mu Y; Cheng Y
Stem Cell Res Ther; 2022 Mar; 13(1):109. PubMed ID: 35313972
[TBL] [Abstract][Full Text] [Related]
16. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
[TBL] [Abstract][Full Text] [Related]
17. Glycemic control by umbilical cord-derived mesenchymal stem cells promotes effects of fasting-mimicking diet on type 2 diabetic mice.
Zhao N; Gao YF; Bao L; Lei J; An HX; Pu FX; Cheng RP; Chen J; Ni H; Sui BD; Ji FP; Hu CH
Stem Cell Res Ther; 2021 Jul; 12(1):395. PubMed ID: 34256832
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells.
Wu LF; Wang NN; Liu YS; Wei X
Tissue Eng Part A; 2009 Oct; 15(10):2865-73. PubMed ID: 19257811
[TBL] [Abstract][Full Text] [Related]
19. Impact of repeated intravenous infusions of umbilical cord-derived versus bone marrow-derived mesenchymal stem cells on angiogenesis in a pregnant experimentally induced deep venous thrombosis rat model.
Cheng X; Wang W; Du R; Zhang M; Xie Y; Sun W; Ji J; Sun B; Zhang Y
In Vitro Cell Dev Biol Anim; 2022 Dec; 58(10):957-969. PubMed ID: 36469244
[TBL] [Abstract][Full Text] [Related]
20. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
Chen MY; Lie PC; Li ZL; Wei X
Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
